Jephesson A. dos Santos

Jephesson A. dos Santos

Auto-generated profile, based on publicly available information

Jephesson A. dos Santos

Departamento de Biofísica, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Cancer Research
Verified
Journal Article
Closed access
PDF file
GLGuido Lenz
Guido Lenz
GOGiovana R. Onzi
Giovana R. Onzi
LLLuana S. Lenz
Luana S. Lenz
JBJulieti H. Buss
Julieti H. Buss
JSJephesson A. dos Santos
Jephesson A. dos Santos
KBKarine R. Begnini
Karine R. Begnini
Heterogeneity is a pervasive feature of cancer, and understanding the sources and regulatory mechanisms underlying heterogeneity could provide key insights to help improve the diagnosis and treatment of cancer. In this review, we discuss the origin of heterogeneity in the phenotype of individual cancer cells. Genotype–phenotype (G–P) maps are widely used in evolutionary biology to represent the complex interactions of genes and the environment that lead to phenotypes that impact fitness. Here, we present the rationale of an extended G–P (eG–P) map with a cone structure in cancer. The eG–P cone is formed by cells that are similar at the genome layer but gradually increase variability in the epigenome, transcriptome, proteome, metabolome, and signalome layers to produce large variability at the phenome layer. Experimental evidence from single-cell-omics analyses supporting the cancer eG–P cone concept is presented, and the impact of epimutations and the interaction of cancer and tumor microenvironmental eG–P cones are integrated with the current understanding of cancer biology. The eG–P cone concept uncovers potential therapeutic strategies to reduce cancer evolution and improve cancer treatment. More methods to study phenotypes in single cells will be the key to better understand cancer cell fitness in tumor biology and therapeutics.